Mental Health Services

Epworth Centre for Innovation in Mental Health

Epworth Centre for Innovation in Mental Health

Add to favourites

About Us

INVESTIGATING A NOVEL TREATMENT FOR ALZHEIMER’S DISEASE      

The Epworth Centre for Innovation in Mental Health (ECIMH) is investigating a new treatment for people with Alzheimer’s disease. Our research is examining whether transcranial magnetic stimulation (TMS) can improve the cognitive symptoms of mild to moderate Alzheimer’s disease such as memory and thinking difficulties.

PURPOSE OF THIS RESEARCH
The Epworth Centre for Innovation in Mental Health (ECIMH) is investigating a new treatment for people with Alzheimer’s disease. Our research is examining whether transcranial magnetic stimulation (TMS) can improve the cognitive symptoms of mild to moderate Alzheimer’s disease such as memory and thinking difficulties.

WHAT IS TRANSCRANIAL MAGNETIC STIMULATION?
TMS is a form of non-invasive brain stimulation which uses a magnetic pulse to stimulate brain cells. A coil is placed on your head whilst you are seated comfortably in a chair, with the magnetic field increasing activity in the cells underneath the coil during active TMS. TMS has been used for over 20 years in the treatment of depression. It has been shown to be a safe and effective treatment for that condition. We are now testing its use in the treatment of Alzheimer’s disease. You will be randomly selected to receive either active or placebo (inactive) TMS. If you were randomised to the placebo group you will be offered active stimulation at the end of
the follow-up period.

WHO IS ELIGIBLE TO PARTICIPATE?

  • Men and women, aged 50 – 95 years
  • With a diagnosis of mild to moderate Alzheimer’s disease
  • Interested in participating

 

ABOUT US
We use advanced neuroscience technology to investigate brain function and develop innovative treatments across a range of psychiatric, neurological and neurodegenerative disorders.

ABOUT THE PRINCIPAL INVESTIGATORS
A/Prof Kate Hoy is a Clinical Neuropsychologist and heads the Cognitive Therapeutics Research Program and is Deputy Director of the Therapeutic Brain Stimulation division.
E: [email protected]


Prof Paul Fitzgerald is a Psychiatrist and Director of the Therapeutic BrainStimulation division.
E: [email protected]

FOR MORE INFORMATION ABOUT THE ALZHEIMER’S CLINICAL TRIALS, CONTACT:
Dr Melanie Emonson
Research Officer
Phone: (03) 9805 4346
[email protected]

Ms Veronika Simic
Research Officer
Phone: (03) 9076 8650
[email protected]

WHERE WE ARE LOCATED
Epworth Centre for Innovation in Mental Health
888 Toorak Rd
Camberwell VIC 3124
Phone: (03) 9805 4363
Fax: (03) 9805 4188

The research outlined has been approved by the ethics committee of The Alfred Hospital.

Quick Facts About The Region

Epworth Centre for Innovation in Mental Health is located in the suburb of Camberwell, the council of Boroondara City and the federal electorate of Higgins.